Sung Bo Chemicals Co., LTD

KRX:003080.KS

2620 (KRW) • At close September 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 62,612.4466,379.25857,675.73651,733.62941,863.99849,517.68158,368.80958,011.68156,047.13454,541.84349,657.47545,320.18441,202.63235,223.25744,400.76240,370.14137,729.219
Cost of Revenue 46,085.88448,472.3843,167.10342,155.62933,396.25336,073.82746,276.04643,153.01937,840.57336,602.00834,575.2532,021.94430,197.48427,074.09832,243.91627,518.226,217.775
Gross Profit 16,526.55617,906.87814,508.6339,5788,467.74513,443.85412,092.76314,858.66218,206.56117,939.83515,082.22613,298.2411,005.1488,149.15912,156.84612,851.94111,511.444
Gross Profit Ratio 0.2640.270.2520.1850.2020.2710.2070.2560.3250.3290.3040.2930.2670.2310.2740.3180.305
Reseach & Development Expenses 2,034.1681,960.4541,589.3972,086.4782,297.8442,527.1483,176.0682,467.6342,401.4592,478.8762,013.5641,927.8171,641.2091,657.9451,294.459579.762559.435
General & Administrative Expenses 2,307.5622,110.1131,643.3731,529.4191,653.9941,611.1821,947.5791,837.6561,712.2641,807.6941,596.2721,451.3151,349.707903.216792.761,048.809851.425
Selling & Marketing Expenses 1,693.1941,821.4351,630.0741,437.461,359.831,575.2991,729.9991,875.7951,757.9111,637.3031,398.2911,351.2181,303.5941,271.8651,197.7011,187.0541,279.552
SG&A 13,658.6063,931.5483,273.4472,966.8793,013.8243,186.4813,677.5783,713.4513,470.1753,444.9972,994.5632,802.5332,653.3012,175.0811,990.4612,235.8632,130.977
Other Expenses -546.8410,109.9298,607.3868,237.0597,509.0857,437.035,670.814-169.307196.012130.206-82.71111.8395,244.721610.795-792.385-330.504-262.144
Operating Expenses 16,239.61416,001.93113,470.2313,290.41612,820.75313,150.65914,846.96213,578.77912,754.64412,634.6211,294.36210,513.7099,539.2318,640.7218,429.736,971.3937,020.837
Operating Income 286.9413,110.462,000.124-826.578-2,968.649494.308-2,754.1961,279.8835,451.9175,305.2143,787.8642,784.5311,598.438-491.5613,727.1165,880.5494,490.606
Operating Income Ratio 0.0050.0470.035-0.016-0.0710.01-0.0470.0220.0970.0970.0760.0610.039-0.0140.0840.1460.119
Total Other Income Expenses Net 1,304.72-580.384-205.527-4,299.857-1,047.0586,946.73113,428.54296,342.94440.528264.533474.073828.829415.492798.539674.797-50.694139.664
Income Before Tax 1,591.6612,530.0761,794.597-5,126.435-4,015.7077,441.03810,674.34397,622.8275,492.4465,569.7484,261.9373,613.361,881.409306.9774,401.9135,829.8544,630.271
Income Before Tax Ratio 0.0250.0380.031-0.099-0.0960.150.1831.6830.0980.1020.0860.080.0460.0090.0990.1440.123
Income Tax Expense 428.231-1,406.29513.981877.517-1,147.2171,306.1211,401.42822,582.9132,227.125945.91771.706639.59599.427247.215835.1611,506.2281,276.542
Net Income 1,277.3584,014.5631,360.599-6,003.952-2,868.4916,134.9179,272.91575,039.9143,265.324,623.8383,490.2312,973.7641,781.98359.7623,566.7524,323.6263,353.729
Net Income Ratio 0.020.060.024-0.116-0.0690.1240.1591.2940.0580.0850.070.0660.0430.0020.080.1070.089
EPS 65.21204.1369.33-306.67-144.573094713,74816.3231174.3148.5893178.2216167.5
EPS Diluted 65.21204.1369.33-306.67-144.573094713,74816.3231174.3148.5893178.2216167.5
EBITDA 3,235.866,108.1424,960.0162,511.193500.0983,556.4197,462.8222,990.386,709.4496,763.9725,069.4284,875.5613,126.711,751.7566,000.2437,019.5355,716.171
EBITDA Ratio 0.0520.0920.0860.0490.0120.0720.1280.0520.120.1240.1020.1080.0760.050.1350.1740.152